Darwin Advisors, LLC Eli Lilly & CO Transaction History

Darwin Advisors, LLC

$356 Million
Q3 2024

A detailed history of Darwin Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Darwin Advisors, LLC holds 426 shares of LLY stock, worth $318,652. This represents 0.11% of its overall portfolio holdings.

Number of Shares

426

Holding current value

$318,652

% of portfolio

0.11%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$772.14 - $960.02 $328,931 - $408,968	426 New	426 $377,000
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $29,017 - $38,821	-49 Reduced 9.21%	483 $375,000
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $49,367 - $58,198	-94 Reduced 15.02%	532 $310,000
Q3 2023 Nov 07, 2023	BUY	$434.7 - $599.3 $6,520 - $8,989	15 Added 2.45%	626 $336,000
Q2 2023 Jul 12, 2023	BUY	$350.74 - $468.98 $214,302 - $286,546	611 New	611 $286,000
Q4 2022 Jan 17, 2023	SELL	$321.55 - $374.67 $1.71 Million - $2 Million	-5,333 Reduced 78.58%	1,454 $0
Q3 2022 Oct 18, 2022	BUY	$296.48 - $337.87 $1.56 Million - $1.78 Million	5,272 Added 347.99%	6,787 $2.26 Million
Q2 2022 Aug 03, 2022	BUY	$278.73 - $327.27 $155,531 - $182,616	558 Added 58.31%	1,515 $485,000
Q4 2021 Jan 21, 2022	BUY	$224.85 - $279.04 $224 - $279	1 Added 0.1%	957 $233,000
Q3 2021 Oct 27, 2021	SELL	$221.6 - $272.71 $24,597 - $30,270	-111 Reduced 10.4%	956 $221,000
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $192,646 - $249,187	1,067 New	1,067 $245,000
Q3 2020 Oct 16, 2020	SELL	$146.22 - $169.13 $2.91 Million - $3.37 Million	-19,921 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$136.42 - $164.18 $2.54 Million - $3.06 Million	18,629 Added 1441.87%	19,921 $3.27 Million
Q1 2020 May 01, 2020	BUY	$119.05 - $147.35 $153,812 - $190,376	1,292 New	1,292 $178,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$72.5 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$55.2 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$49.3 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$38.4 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$25.3 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Darwin Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Darwin Advisors, LLC with notifications on news.

Account